HIV INTEGRASE INHIBITORS
    45.
    发明公开
    HIV INTEGRASE INHIBITORS 审中-公开
    HIV整合酶抑制剂

    公开(公告)号:EP1725535A2

    公开(公告)日:2006-11-29

    申请号:EP05724616.7

    申请日:2005-03-04

    申请人: Merck & Co., Inc.

    CPC分类号: C07D471/04 C07D471/10

    摘要: Compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: (I) wherein Z, R1, R2, R3, R4, R5, R6, R7, R8 and R9 are defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

    摘要翻译: 式I化合物为HIV整合酶抑制剂和HIV复制抑制剂:(I)其中Z,R1,R2,R3,R4,R5,R6,R7,R8和R9如本文所定义。 这些化合物可用于预防和治疗HIV感染以及预防,延缓艾滋病的发作和治疗。 这些化合物本身作为化合物或以药学上可接受的盐的形式用于抗HIV感染和AIDS。 化合物及其盐可以用作药物组合物中的成分,任选地与其他抗病毒剂,免疫调节剂,抗生素或疫苗组合使用。